Epilepsy Therapies & Diagnostics Development (ETDD)
Synapcell's speech at epilepsy therapies & diagnostics development XVII As…
CNS Therapeutics XChange 2023 East Coast and Essential Tremor Congress
In May, SynapCell participates to two events on the US…
SynapCell Sponsor of ASENT 2023
synapcell sponsor of asent 2023 ASENT is a neuroscience and…
Society for Neuroscience 2022 – San Diego
synapcell exhibitor at society for neuroscience Society for Neuroscience is…
CNS Therapeutics Xchange 2022 – Europe Zürich
SYNAPCELL SPONSORS THE CNS XCHANGE 2022 – EUROPE HubXchange’s Europe…
CNS Therapeutics Xchange 2022 – US West Coast
SYNAPCELL SPONSORS THE CNS XCHANGE 2022 HubXchange’s West Coast CNS…
SynapCell’s experts hit the West Coast road ! [June 2022]
FINALLY BACK ON THE ROAD… Taking advantage of two major…
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease
ADDRESSING LDOPA INDUCED DYSKINESIA IN PARKINSON'S: POSTER COMMUNICATION [Abstract] Thanks…
ASENT 2022
SynapCell sponsors the ASENT 2022 Annual Meeting The Annual American…
AES 2021: Partnership with OVID Threapeutics in Epilepsy
The American Epilepsy Society Annual Meeting is taking place in…
CNS Therapeutics Xchange 2021
https://synapcell.com/wp-content/uploads/2021/11/HubXchange-CNS-Therapeutics_Preclinical-1.mp4 PROUD TO BE SPONSORING This year HubxChange Europe will…
Society for Neuroscience 2021
Celebrating 50 years of the Society for Neuroscience The Society…